BRIEF-Aveo Pharmaceuticals Inc Says CANbridge Life Sciences Ltd Exercised Its Right To Terminate Agreement With Co Pertaining To AV-203

Reuters · 03/15/2021 20:47
BRIEF-Aveo Pharmaceuticals Inc Says CANbridge Life Sciences Ltd Exercised Its Right To Terminate Agreement With Co Pertaining To AV-203

- Aveo Pharmaceuticals Inc AVEO.O:

  • AVEO PHARMACEUTICALS INC - ON MARCH 9, 2021, CANBRIDGE LIFE SCIENCES LTD. EXERCISED ITS RIGHT TO TERMINATE AGREEMENT WITH CO PERTAINING TO AV-203

  • AVEO PHARMACEUTICALS INC - TERMINATION IS EFFECTIVE AS OF SEPTEMBER 5, 2021

  • AVEO PHARMACEUTICALS INC - PURSUANT TO TERMS OF AGREEMENT, COMPANY EXPECTS TRANSFER OF AV-203 PROGRAM TO BE COMPLETE BY EFFECTIVE DATE

  • AVEO PHARMACEUTICALS INC - COMPANY EXPECTS TO REGAIN RIGHTS TO AV-203 PROGRAM OUTSIDE OF NORTH AMERICA BY EFFECTIVE DATE

Source text: [ID: https://bit.ly/3vvxHxc]

Further company coverage: AVEO.O


((Reuters.Briefs@thomsonreuters.com;))